Shifa International Hospitals Limited (PSX: SHFA)
Pakistan
· Delayed Price · Currency is PKR
425.05
-7.31 (-1.69%)
At close: Feb 4, 2025
PSX:SHFA Revenue
Shifa International Hospitals had revenue of 7.06B PKR in the quarter ending September 30, 2024, with 18.85% growth. This brings the company's revenue in the last twelve months to 24.67B, up 18.05% year-over-year. In the fiscal year ending June 30, 2024, Shifa International Hospitals had annual revenue of 23.55B with 19.57% growth.
Revenue (ttm)
24.67B
Revenue Growth
+18.05%
P/S Ratio
1.09
Revenue / Employee
4.61M
Employees
5,348
Market Cap
26.87B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 23.55B | 3.85B | 19.57% |
Jun 30, 2023 | 19.70B | 3.51B | 21.66% |
Jun 30, 2022 | 16.19B | 1.97B | 13.84% |
Jun 30, 2021 | 14.22B | 1.96B | 16.02% |
Jun 30, 2020 | 12.26B | 486.22M | 4.13% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
GlaxoSmithKline Pakistan | 56.23B |
Abbott Laboratories (Pakistan) | 63.81B |
The Searle Company | 28.32B |
Highnoon Laboratories | 23.02B |
Citi Pharma | 12.93B |
Ferozsons Laboratories | 15.96B |
Otsuka Pakistan | 3.18B |